Estrogen receptor ␣ and ␤ proteins (ER␣ and ER␤) at various stages of development of the rat mammary gland were quantified by Western blotting. ER␣ and ER␤ recombinant proteins were used as standards, and their molar concentrations were measured by ligand binding assays. In 3-week-old pregnant, lactating, and postlactating rats the ER␣ content ranged from 0.30 -1.55 fmol/g total protein (mean values). The ER␤ content of the same samples ranged between 1.06 -7.50 fmol/g total protein. At every developmental stage, the ER␤ content of the mammary gland was higher than that of ER␣. When receptor levels were normalized against ␤-actin, it was evident that ER expression changed during development, with maximum expression of both receptors during the lactation period. With an antibody raised against the 18-amino acid insert of the ER␤ variant, originally called ER␤2 but named ER␤ins in this paper, Western blots revealed that ER␤ins protein was up-regulated during the lactation period. RT-PCR showed that the levels of messenger RNA of ER␤ins paralleled those of the protein. Double immunohistochemical staining with anti-ER␣ and anti-ER␤ins antibodies revealed that ER␤ins protein colocalized with ER␣ in 70 -80% of the ER␣-expressing epithelial cells during lactation and with 30% of these cells during pregnancy. These observations indicate that expression of ER␤ins is regulated not only quantitatively, but also with regard to its cellular distribution. As ER␤ins acts as the dominant repressor of ER␣, we suggest that its coexpression with ER␣ quenches ER␣ function and may be one of the factors that contribute to the previously described insensitivity of the mammary gland to estrogens during lactation. (Endocrinology 142: [3177][3178][3179][3180][3181][3182][3183][3184][3185][3186] 2001) I T IS WELL documented that estrogen is an obligatory factor for the development of the mammary gland (1, 2). Most of the actions of estrogen are mediated by two estrogen receptors (ER), ER␣ and ER␤, cloned in 1986 (3) and 1996 (4), respectively. In their DNA-binding domains (5), ER␣ and ER␤ share 96% homology and recognize the same estrogenresponsive element (ERE) on genomic DNA. In their ligandbinding domains (LBD) there is only 60% homology, and this results in some degree of ligand selectivity between the receptors; indeed, compared with ER␣, ER␤ has a lower affinity for estradiol (E 2 ), but a higher affinity for genistein (5, 6). For full transcriptional activity in an ERE reporter assay using 293 cells with transfected ERs, a 10-fold higher concentration of E 2 is required for ER␤ than for ER␣, whereas a 10-fold lower concentration of genistein can activate ER␤ (7). Although, on classical EREs, both ER␣ and ER␤ activate transcription, they can work in opposite directions on activating protein-1 response elements (8). In the presence of E 2 , ER␣ is an activator, but ER␤ is an inhibitor or silencer, at activating protein-1 sites (8). Moreover, recent publications provide evidence that ER␤ is not simply an ER that utilizes ligands other than those used by ER␣, but is an independent regulator with distinct cellular functions (9 -11).
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I T IS WELL documented that estrogen is an obligatory
factor for the development of the mammary gland (1, 2) . Most of the actions of estrogen are mediated by two estrogen receptors (ER), ER␣ and ER␤, cloned in 1986 (3) and 1996 (4), respectively. In their DNA-binding domains (5) , ER␣ and ER␤ share 96% homology and recognize the same estrogenresponsive element (ERE) on genomic DNA. In their ligandbinding domains (LBD) there is only 60% homology, and this results in some degree of ligand selectivity between the receptors; indeed, compared with ER␣, ER␤ has a lower affinity for estradiol (E 2 ), but a higher affinity for genistein (5, 6) . For full transcriptional activity in an ERE reporter assay using 293 cells with transfected ERs, a 10-fold higher concentration of E 2 is required for ER␤ than for ER␣, whereas a 10-fold lower concentration of genistein can activate ER␤ (7) . Although, on classical EREs, both ER␣ and ER␤ activate transcription, they can work in opposite directions on activating protein-1 response elements (8) . In the presence of E 2 , ER␣ is an activator, but ER␤ is an inhibitor or silencer, at activating protein-1 sites (8) . Moreover, recent publications provide evidence that ER␤ is not simply an ER that utilizes ligands other than those used by ER␣, but is an independent regulator with distinct cellular functions (9 -11).
There are three potential translational start sites at the 5Ј-end of rat ER␤ messenger RNA (mRNA), which, if used, would produce proteins 485, 530, and 549 amino acids (aa) in length, differing at their N-termini (12) . Similar sites are found in the human ER␤ sequence and result in polypeptide chains that are 477, 485, and 530 aa in length (12, 13) . Fuqua et al. reported that 530-and 477-aa proteins can be produced in cells transfected with the human full-length complementary DNA (cDNA) (14) . However, it is not yet clear whether products of different sizes are normally expressed in tissues. From the few studies in which Western blotting of tissue extracts have been made, the longest ER␤ form seems to be the major component (14, 15) . As differences at the Nterminus may affect the ligand-independent transcriptional activity of the activating factor-1 domain (16) , this issue needs further analysis.
Although these N-terminal differences do not change the ligand-binding character of ER␤, some of the alternatively spliced variants, which have been reported in human, mouse, and rat, have weak affinities for E 2 and seem to be very important in terms of their relation to the function of ER␣. One ER␤ variant, first reported as ER␤2 by Petersen et al. (17) and named ER␤ins in this paper, has a 54-bp (18-aa) additional in-frame sequence between exons 5 and 6 of wildtype (wt) rat ER␤. This insertion causes about 1/35-fold lower binding affinity for E 2 (17, 18) . As the capacity for DNA binding and dimerization with ER␣ and wt ER␤ remains intact, ER␤ins can act as a negative regulator when it is coexpressed with ER␣ or wt ER␤ (17, 18) . In humans, a C-terminally truncated variant, named ER␤2 by Moore et al. (19) and ER␤cx by Ogawa et al. (20) , does not bind E 2 and is a dominant negative regulator for ER␣, but not for wt ER␤ (19, 20) .
Information about the tissue distribution of ER␣ and ER␤ proteins is necessary for understanding the specific physiological functions of these two receptors. Granulosa cells of ovary and epithelial cells of ventral prostate express ER␤ exclusively (4, 21) , and analysis of these tissues can provide information about which genes are ER␤ regulated. On the other hand, in the mammary gland, at least in humans and rats, both ER␣ and ER␤ are expressed (15, (22) (23) (24) . In this case, interaction between the two receptors in individual cells may be very important for the overall effect of estrogen on the whole tissue.
Recent reports suggested the importance of wt ER␤ as a regulator of ER␣ function. For example, Pettersson et al. reported that wt ER␤ can dose dependently down-regulate ER␣'s trans-activation potency when the concentration of E 2 is not sufficient for activation of ER␤ (7). As described previously, rat ER␤ins and human ER␤cx are dominant negative regulators of ER␣ independent of the E 2 concentration (17) (18) (19) (20) . All of these findings indicate that for an understanding of the role of ERs in tissues where ER␣ and ER␤ are coexpressed, information is needed about the degree of colocalization of ER␣ with ER␤ and its variants and on the relative quantities of the two receptors.
In this study we evaluated the expression and colocalization of ER␣, ER␤, and one ER␤ variant, ER␤ins, in rat mammary gland using quantitative Western blotting and immunohistochemistry. The results suggest a possible role for ER␤ins in silencing of ER␣ function during the lactating period.
Materials and Methods Animals
Preparation and management of mating of Sprague-Dawley rats were performed as described previously (15) . Briefly, virgin cycling 6-weekold female rats were mated during proestrus with 9-week-old males. The day when the vaginal plug was evident was designated day 0 of pregnancy. Pregnant females were placed in separate cages and killed on days 2, 7, and 14 of pregnancy. The day of parturition was designated day 0 of lactation. Lactating animals were killed on days 2, 7, and 14. In another group, pups were removed from their mothers on day 22 of lactation. These mothers were killed 7 days after weaning, and female pups were killed at 3, 4, 5, and 6 weeks of age. The inguinal mammary glands were excised and used for further experiments.
Recombinant proteins as positive control
Recombinant ER␣ and ER␤1 (ER␤ 530) proteins were purchased from Panvera (Madison, WI). The amount of functional receptor was measured by a tritium-labeled E 2 binding assay. Both of the human recombinant proteins were made from baculovirus-infected cells and had ER concentrations of 7.3 pmol/l (ER␣) and 1 pmol/l (ER␤ 530). The ER␤ 503 protein is composed of the human 485-aa sequence with the rat 18 aa of rat ER␤ins (17) . This was produced by overexpression in SF9 cells by Karo Bio AB (Huddinge, Sweden). This form of ER␤ (ER␤ins) has very little binding affinity for E 2 , but its affinity for 4-hydroxytamoxifen is similar to that of ER␤ 530. All proteins were divided into small aliquots and thawed only once to avoid degradation.
Antibodies
ER␣ 6F11, a mouse monoclonal antibody, was obtained from Novo Castra (Newcastle upon Tyne, UK). ER␤ LBD rabbit polyclonal antibody was produced by us as described previously (15 
Protein extraction for Western blotting
For efficient extraction of all nuclear receptors from the tissue and for the visualization of sharp bands that can be correctly measured by the photoimager, modifications were made to the protocols previously reported (15) . Tissues were removed from animals, placed in ice-cold lysis buffer, and homogenized immediately. Lysis buffer was composed of 600 mm Tris-HCl, 1 mm EDTA (pH 7.4), and two protease inhibitor tablets (Roche Molecular Biochemicals, Mannheim, Germany)/50 ml. The homogenates were centrifuged for 1 h at 105,000 ϫ g, and the protein concentrations of supernatant were measured by protein assay (Bio-Rad Laboratories, Inc., Hercules, CA) with BSA as standard.
Direct usage of this sample on SDS-PAGE resulted in less stacking as well as fuzzy protein bands, probably due to the high salt concentration.
To overcome these problems, 65 g of each sample were precipitated with trichloroacetic acid (10% final) and resuspended in 100% methanol. Samples were placed on dry ice for 30 min, and the protein was recovered by centrifugation. Precipitates were dissolved in 1 ϫ SDS sample buffer and used for SDS-PAGE.
Western blotting analysis
Samples were resolved on SDS-polyacrylamide gels, either 9% polyacrylamide or preformed gradient gels 4 -20% acrylamide (Novex, San Diego, CA), with a Tris-glycine buffer system. Transfer to ProBlot membranes (PE Applied Biosystems, Foster City, CA) by electroblotting was performed either by semidry or wet blotting or in a Tris-glycine buffer. Kaleidoscope prestained standards (Bio-Rad Laboratories, Inc.) and a low mol wt electrophoresis calibration kit (Amersham Pharmacia Biotech, Uppsala, Sweden) were used as mol wt markers.
After 1-h blocking with blocking buffer (10% skim milk in PBS with 0.1% Nonidet P-40) at room temperature, membranes were incubated with a 1:75 dilution of ER␣ 6F11 mouse antibodies, a 1:3000 dilution of ER␤ LBD rabbit antibodies, or a 1:500 dilution of ER␤INS chicken antibodies in blocking buffer at 4 C overnight. This was followed by 1-h washing in blocking buffer and then incubation in a 1:7500 dilution of horseradish peroxidase-conjugated secondary antibodies for each species in blocking buffer for 1 h at room temperature. After sequential washing with blocking buffer, PBS with 0.1% Nonidet P-40, and PBS alone, signals were developed using ECL Plus (Amersham Pharmacia Biotech).
For normalization against an intracellular protein, the membranes used for ER␣ or ER␤ detection were sequentially probed with a ␤-actinspecific antibody without stripping the membrane as described by Liao et al. (25) . Bands on the exposed film were captured with an image analyzer (LAS-1000, Fuji Photo Film Co. Ltd., Tokyo, Japan), and densitometric values were measured with Image Garge (Fuji Photo Film Co., Ltd.). Three sets of densitometric values obtained from three separate blots were used for the calculation.
Calculation of protein amount from Western blotting results
By referring to the data and graph obtained from the control study (left graph in Fig. 1B ) and the densitometric values of the recombinant protein on the blots (Fig. 2, A and B) , an approximate formula was drawn by polynomial regression with the StatView program (Abacus Concepts, Inc., Beverly, CA). From triplicate experiments using recombinant proteins, the formula that had the highest r 2 value was chosen (r 2 ϭ 0.996; P Ͻ 0.01 for ER␣ and r 2 ϭ 0.997; P Ͻ 0.01 for ER␤). The molar concentration of ER in each lane was calculated by the selected formula and expressed as femtomoles per g total protein extract. From the calculated value of three independent Western blots using three sets of samples, the mean and sd were calculated.
In addition to expressing the receptor content per g total protein extract, band densities were also normalized against ␤-actin on the same membrane. The mean Ϯ sd were expressed graphically in Fig. 4 . Statistical analysis was performed by unpaired Welch's t test.
RT-PCR study
Total RNA was extracted from frozen mammary gland tissue using RNAwiz (Ambion, Inc., Austin, TX) according to the manufacturer's instructions and quantified spectrophotometrically. Two micrograms of total RNA were treated with 5 U ribonuclease-free deoxyribonuclease (DNase; Promega Corp., Madison, WI) for 30 min at 37 C to remove genomic DNA from the RNA samples. After inactivation of DNase for 10 min at 65 C, removing the enzyme by phenol extraction, and ethanol precipitation of the RNA, samples were reverse transcribed using the SuperScript preamplification system (Life Technologies, Inc., Gaithersburg, MD) in a final volume of 20 l according to the manufacturer's instructions.
The primer sets for detecting both wt and ␤ins variants in one reaction were rER␤ LBD U (5Ј-GAGCTCAGCCTGTTCGACC) and rER␤ LBD L (5Ј-GGCCTTCACACAGAGATACTCC) (18) . The primer sets for detecting only ER␤ins were rER␤ INS U (5Ј-ATTATAAATATACTATATCAT-TAATATTAATCCTCAGAAGACCCT) and rER␤ INS L (5Ј-ATATTA ATATATGTATATTAATTATTTAATGGGCAGCACTCTTCA). For detection of the total amount of ER␤ mRNA, we used rER␤ EX6 U (5Ј-AATCTTTGACATGCTCCTGGCG) and rER␤ EX7 L (5Ј-AAAGAAG-CATCAGGAGGTTGGC). The sizes of respective products are 246 bp for wt and 300 bp for ␤ins when using rER␤ LBD U and L primers. Combination of rER␤ INS U and L primers produces the 110-bp product, and rER␤ EX6 U with EX7 L primer makes the 263-bp band as a total ER␤. Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) primers were 5Ј-CAGCCGCATCTTCTTGTG for sense and 5Ј-AGTTGTCATATT-TCTCGTGGTTCA for antisense.
PCR reactions were 95 C for 5 min, cycle step, and 72 C for 5 min with TaqStart antibody for hot start (CLONTECH Laboratories, Inc. Palo Alto, CA). Cycle steps for each primers were as follows: rER␤ LBD U and L, 36 cycles at 95 C for 30 sec, 57 C for 40 sed, and 72 C for 60 sec; rER␤ INS U and L, 39 cycles at 95 C for 30 sec, 51 C for 30 sec, and 72 C for 50 sec; rER␤ EX6 and EX7U, 35 cycles at 95 C for 30 sec, 57 C for 30 sec, and 72 C for 60 sec; and GAPDH, 26 cycles at 95 C for 30 sec, 56 C for 40 sec, and 72 C for 60 sec. Cycle numbers were decided by the control study, which confirmed the linear phase of reaction (data not shown). For reactions with rER␤ INS U and L primers, a minimum of 38 cycles was needed for detection of the band.
PCR products were resolved on a 2% agarose gel containing ethidium bromide in 0.5 ϫ Tris-borate EDTA running buffer. Products as total ER␤ and ER␤ins were loaded in one lane on an agarose gel (second panel of Fig. 5B ). The 123-bp DNA ladder obtained from Life Technologies, Inc. was used for calibration. The negative control in each set was a reaction where the cDNA template was replaced with DNase-treated RNA (data not shown), and the identity of the positive band was confirmed by direct sequencing of the representative PCR product or by cloning the PCR product into a TA cloning vector, selection of clones, and sequencing of the insert from the vector.
Band density in three independent experiments was measured by the same system used for evaluation of Western blots. Values of total ER␤ mRNA were normalized against those of GAPDH and expressed as the fold increase when the mean value of the 3-week-old sample was arbitrarily set at 1. All PCR reactions were performed in triplicate for each target.
Immunohistochemical staining
Double immunohistochemical staining using fluorescence-conjugated secondary antibody was performed as described previously (15) . Briefly, frozen sections from rat mammary gland were fixed with icecold methanol, acetone, and 4% paraformaldehyde. After treatment with 0.5% Triton X-100 in PBS and 10% normal serum from the same species as the secondary antibody, sections were incubated sequentially as follows: ER␣ 6F11 mouse antibody (1:100), fluorescein isothiocyanate (FITC)-conjugated antimouse IgG (1:50), ER␤ INS chicken antibody (1: 500), and Cy3-conjugated anti chicken IgY (1:200). Nuclear staining was performed with 0.1 g/ml 4Ј,6-diamidino-2-phenylindole (DAPI). The sections were examined under the fluorescence microscope with suitable filters for FITC, Cy3, and DAPI, and images captured by CCD camera were analyzed with OpenLab 2.03 program (Improvision, Covently, UK). To have accurate evaluation, counting of positively labeled cells was assisted by this program, which could clearly mark the labeled cells less ambiguously than the human eye. Counting analysis was performed on six pictures produced from three individual samples in each category.
For the control study of our antibody, 1 l ER␤ INS antibody was incubated with an excess of ER␤ 503 protein or ER␤ 530 protein in PBS at 4 C overnight. These preadsorbed antibodies with PBS were applied to sections at 1:200 -300 dilution. Fig. 1A , both recombinant proteins showed a clear single band with no evidence of degradation. The relationship between the densitometric value of ER␣ and ER␤ bands on the blots and the amount of protein is shown in Fig.  1B . From these results, a regression line was drawn, and a formula for calculating the amount of receptor protein from the band densities was made (left graph in Fig. 1B) 
Results

Control study for quantitative Western blotting
No quantitative data on the relative amounts of ER␣ and ER␤ proteins expressed in tissues are available to date. Such information is essential for evaluation of functional interaction between these receptors. To determine their relative abundance in rat mammary gland, we developed a quantitative Western blot assay for ER␣ and ER␤. By comparison of the band densities of recombinant proteins whose molar concentrations were predetermined by binding assays and those of samples, we could calculate the content of receptor protein in tissue samples. The receptor concentrations in recombinant human ER␣ and ER␤ proteins, purchased from Panvera, were assessed by a tritium-labeled E 2 binding assay. As shown in
Evaluation of ER␣ and ER␤ proteins by quantitative Western blotting
Aliquots containing 65 g total protein from extracts of mammary glands at each developmental stage were loaded onto gels with calculated amounts of recombinant protein in adjacent lanes (Fig. 2) . On Western blots, the ER␣ antibody detected a single band in tissue samples, and this band comigrated with recombinant ER␣ protein, which migrated as a 66-to 67-kDa band ( Fig. 2A) . With the ER␤ LBD antibody (Fig. 2B) there were three bands in rat mammary gland tissues. Figure 2D is a high magnification of the bands of the blot of the three individual samples from 3-week-old rats. The main bands were in the 62-kDa range. The largest band was very weak, with a size of approximately 65 kDa. As shown in Fig. 2B , ER␤ LBD antibody did not recognize 0.5 pmol ER␣ protein, but clearly detected 0.5 pmol ER␤ 530 protein, which migrated as a 62-kDa band. The 65-kDa band, therefore, also due to the difference in size, cannot be ex- Three sets of experiments using three individual series of samples were performed and used for calculation of amount of protein and evaluation of expression pattern (Table 1 and Fig. 4 ). plained as a cross-reaction with ER␣. As the most likely explanation for this band is that it represented nonspecific reaction, we did not include it in the quantitative analysis. ER␤ LBD antibody also detected recombinant ER␤ 503 protein, which is composed of the 485-aa sequence of human ER␤ with an additional 18-aa rat sequence of ER␤ins in LBD (Fig. 3) . ER␤ 503 protein was observed as a band around 58 -59 kDa. This indicates that ER␤ LBD polyclonal antibody must recognize not only wt, but also ER␤ins protein. In addition, by comparison of the signal of ER␤ 530 with that of the LBD antibody, we could make the rough estimate that the amount ER␤ 503 loaded per lane was approximately 0.5 pmol. From these findings, we conclude that the main 62-kDa bands probably represent 1) wild-type ER␤, translated from the first methionine of mRNA resulting in a 530-aa-long protein; and 2) ER␤ins, expected to have 530 plus 18 aa. We observed that a difference of 18 aa between two ER␤ proteins is not sufficient to allow separation by SDS-PAGE on 9% gels (data not shown). In addition, we developed a specific antibody that only detects ER␤ins protein. ER␤ INS antibody was raised against the specific 18-aa polypeptide of rat ER␤ins (17) . This antibody detected ER␤ 503 protein, but not ER␤ 530 protein (Fig. 2C) . In mammary gland samples, this antibody recognized two bands, one around 62 kDa and the other one around 58 -59 kDa (Fig. 2C) . The relative intensities of these two bands varied between samples. Although the 62-kDa band migrates with the main band observed with the LBD antibody and is expected to be 530 plus 18 aa, the 58-to 59-kDa band is only observed with ER␤ INS antibody. The source of this lower band is uncertain, and it is being further investigated. It could be an ER␤ins composed of 485 plus 18 aa (503 aa in total), a combination of an exon 3 deletion with ER␤ins (17), or a degraded form of ER␤ins that could not be detected by LBD antibody.
Quantification of ER proteins
To compare the amounts of ER proteins per g tissue, the band densities on the blot were measured by photoimager and calculated as moles of receptor. On the ER␤ blots with LBD antibody, the largest band was not included. The calculated receptor content ranged between 0.02-0.15 pmol/ lane for ER␣ and 0.10 -0.50 pmol/lane for ER␤. As is evident from the results shown in Table 1 , ER␤ was more abundant than ER␣ at every developmental stage of the mammary gland.
Changes in expression of ERs normalized against ␤-actin
As is evident from Fig. 2 , when equal amounts of cytosolic protein from mammary glands at various stages were loaded in each lane, the increase in the receptor content of the gland at lactation was not evident. This is because at lactation milk proteins contribute significantly to the soluble proteins, and the amount of truly cytosolic protein loaded in the samples is less than that at other stages. In an attempt to circumvent the problem of milk protein contamination of the cytosol, all densitometric values were normalized against ␤-actin. The ␤-actin level in each sample was evaluated by Western blotting of the membranes after analysis of ER␣ or ER␤. With ␤-actin as an internal standard it is clear that both ER␣ and ER␤ proteins had a peak of expression during lactation (Fig.  4, A and B) . With the same standardization procedure, Western blots with ER␤ins-specific antibody revealed that the expression of ER␤ins protein seemed to be regulated independently of wt ER␤ (Fig. 4C) .
Changes in mRNA expression
To determine whether transcription was involved in the change in expression of wt ER␤ and ER␤ins, an RT-PCR study detecting wt ER␤ and ER␤ins mRNAs was performed. The first set of PCR primers is designed for detecting both wt and ␤ins in one reaction and for evaluating the ratio of these mRNAs (Fig. 5A) (18) . However, although Lu et al. reported the exact expression ratio of these mRNAs by using essentially the same approach for mouse samples (26), our experience has been that the ratios of wt to ␤ins were not reproducible when the difference in amounts of wt and ␤ins were small. Accordingly, we present these data to indicate the relative abundance of wt and ␤ins mRNAs. As shown in the upper panel of Fig. 5B , the balance between wt and ␤ins expression changed during mammary gland development. It is notable that 3-week-old (immature) rats as well as rats during early pregnancy and late lactation show increased relative levels of ER␤ins mRNA, whereas 4-and 6-week-old rats seem to have a low level of ER␤ins mRNA. To confirm this tendency, we developed two other sets of primers. One set detects the total amount of ER␤, and the second set detects only the insert sequence of ER␤ins. PCR reactions with each set of primers were performed independently, and the resulting products were loaded in one lane on an agarose gel (second panel of Fig. 5B ). As the source of product amplified by ␤ins-specific primer is a very low abundance message, the intensity of the band is not reliable as a semiquantitative measurement. The lower PCR products shown in the second panel of Fig. 5B is the result of 39-cycle amplification using ␤ins-specific primers. An increase in cycle number could not enhance the intensity of the bands in a linear way (data not shown). Due to these difficulties of accurate quantification of ␤ins mRNA, the tendency for a change in ER␤ins mRNA is expressed diagrammatically at the bottom of Fig. 5C . Densitometric values of the bands from total ER␤ primers were normalized against those of GAPDH. Figure 5C shows the change in total ER␤ mRNA expression. In the graph the mean FIG. 3 . Scheme of the recombinant ER␤ proteins used. 530 aa ER␤ indicates the human ER␤ protein translated from the first methionine of the N-terminal sequence. 503 aa ER␤ is a chimera protein that has human 485-aa ER␤ sequence and rat 18-aa sequence (gray zone), which is inserted into the LBD [reported as ER␤2 by Petersen et al. (17) ]. For reference, 485-aa ER␤ is shown. This is the transcript from the second methionine of the human ER␤ sequence and has an identical size as rat ER␤ translated from the third methionine as first reported by Kuiper et al. (4) .
value of 3-week-old rat samples is arbitrarily set at 1. By comparison between the graphs of Fig. 4 , B and C, as well as Fig. 5C , it is apparent that although the variations in levels of ER␤ins protein seem to be related to those of ER␤ins mRNA, the expression of wt ER␤ protein is not directly correlated to the levels of its mRNA. This suggests that mechanisms other than transcriptional control, such as control of degradation and/or of translational efficiency, are involved in regulation of wt ER␤ protein.
Colocalization of ER␤ins with ER␣
In cellular systems, ER␤ins heterodimerizes with and is a dominant negative regulator of ER␣ and wt ER␤ (17, 18) .To gain some insight into the possible physiological role of ER␤ins, we performed double immunostaining using fluorescence-labeled secondary antibodies to evaluate the colocalization of ER␤ins with ER␣. Figure 6 is a control study with lactating mammary gland showing the specificity of ER␤ INS antibody. ER␤ INS antibody gave mainly nuclear staining, but there was, in addition, some cytoplasmic staining that appeared as small dots. The staining pattern was not changed by preadsorption of the antibody with ER␤ 530 protein. However, all nuclear staining was abolished when the antibody was preadsorbed with ER␤ 503 protein, which has the 18-aa sequence of ER␤ins (Fig. 3) . Some cytoplasmic staining was left after preadsorption with ER␤ 503. These results suggest that the nuclear staining is specific for ER␤ins. Figure 7 is a representative picture of double staining using ER␣ 6F11 mouse monoclonal antibody with ER␤ INS chicken polyclonal antibody. The green, red, and yellow signals indicate cells expressing ER␣ alone, ER␤ins alone, and both receptors, respectively. Not only epithelial cells, but also some populations of stromal cells (adipocytes), were stained with ER␤ INS antibody. To focus on the possible role of ER␤ins in ER␣ function, we calculated what percentage of ER␣-expressing epithelial cells also expressed ER␤ins. Calculations were made from nuclei in six pictures from three individual samples in each category (bottom of Fig. 7 ). In the pregnant mammary gland only about 30% of ER␣-containing cells express ER␤ins, indicating that in 70% of ER␣-containing cells this receptor is free from ER␤ins. On the other hand, during lactation, 70 -80% of ER␣-containing epithelial cells coexpress ER␤ins. This indicates that a major part of ER␣ in lactation may be antagonized by ER␤ins expressed in the same nuclei, and this may contribute to the insensitivity of the lactating mammary gland to estradiol that was reported 2 decades ago (27) (28) (29) .
Discussion
Since 1996 when rat ER␤ was discovered (4), many laboratories have reported the expression of ER␤ mRNA in various tissues. However, due to the difficulty of obtaining suitable and specific antibodies, there are not many reports on the tissue regulation of ER␤ proteins. In several studies ER␤ mRNA has been measured in the mammary gland, and, in general, compared with ER␣, the level of ER␤ mRNA in the mammary gland of mice and rats is low (5, 17, 30) . We also observed with PCR assays that the level of ER␤ mRNA appears to be lower than that of ER␣. These PCR studies showed that with ER␤ primers, at least 33 cycles of amplification are needed for the detection, but with ER␣-specific primers, PCR products were visible after 27 cycles (data not shown). Upon evaluation of the receptor proteins, however, ER␤ appears to be expressed in more cells than ER␣ in rats and mice (15, 31) . In the case of human samples, Speirs et al. reported that ER␤ mRNA, evaluated by RT-PCR, and ER␤ protein, analyzed by immunohistochemistry, were more frequently detected in epithelial cells of normal mammary gland than ER␣ (23) .
In this report we show that ER␤ protein is more abundantly expressed than ER␣ protein in the rat mammary gland. This is true before puberty, after puberty, during pregnancy, during lactation, and during the postlactation period. The methods used here are based on the assumption that as proteins separated by SDS-PAGE have no threedimensional structure, antibodies recognize epitopes of target protein in samples and in recombinant proteins with the same efficiency. For ER␣ detection we used ER␣ 6F11, which was raised against full-length human ER␣. We cannot rule out the possibility that this antibody recognizes rat ER␣ less efficiently than human ER␣ protein. However, with the homology between human and rat ER␣ of 88% (32) it is unlikely that with the entire protein as antigen there would be significant differences in affinity of the antibody for rat and human ER␣, respectively. Moreover, with another ER␣ antibody, ER␣ MC-20 (Santa Cruz Biotechnology, Inc.), whose antigen is the C-terminal part of mouse ER␣, we obtained results indistinguishable from those presented here (data not shown). For ER␤ detection the same logic applies, as ER␤ LBD antibody was raised against human ER␤ LBD, whose homology to rat is 93% (5) . Even if it may be argued that the numbers generated by our assays do not constitute an accurate representation of the cellular concentrations of the two ERs, it is nonetheless clear that ER␤ protein is more abundantly expressed than ER␣ protein. The differences range from a minimum of 2-fold to a maximum of 10-fold.
In an earlier report we showed Western blotting of ER␤ using similar samples; with that protocol for sample preparation, however, we could not evaluate the molecular size and accurately measure variations in ER␤ protein (15) . When we use a high salt lysis buffer that effectively extracts all DNA-binding proteins, there is a problem of stacking and of Values are the mean Ϯ SD (femtomoles per g total protein). Between days 7 and 14 of pregnancy, the percentage of ER␣-containing cells decreased (15) , but the gland was growing, and the number of ER␣-containing cells as well as the total amount of ER␣ in the gland increased.
broad fuzzy bands on SDS-PAGE (15) . In the present study we overcame this problem with trichloroacetic acid, followed by methanol precipitation (33) and obtained bands that were sharp and strong enough for quantitative evaluation.
It is notable that the changes in ER␤ protein at various stages of mammary gland development were not always paralleled by changes in ER␤ mRNA. For example, although ER␤ mRNA increases in late lactation, ER␤ protein decreases. This discrepancy between mRNA and protein suggests the existence of other critical regulatory mechanisms, such as control of protein degradation and changes in efficiency of translation of mRNA.
Our working hypothesis is that one of the physiological roles of ER␤ is to act as a negative regulatory partner of ER␣. We have already presented evidence for this idea in the rat uterus (34) . In this context, ER␤ variants such as ER␤ins and (Fig. 2) were standardized against those of ␤-actin and expressed as the fold increase when the value for the 3-week-old gland is arbitrarily set at 1. The values were measured in three individual Western blots using three independent sets of samples. Means and SDs are shown on the graph. *, P Ͻ 0.05; **, P Ͻ 0.01 (by unpaired t test). The 5-week-old sample is compared with samples of other ages. Frozen sections from rat mammary gland on day 7 of lactation were stained by the indicated antibodies with Cy-3-conjugated antichicken secondary antibodies. Nuclei were labeled with DAPI, and pictures were taken under a fluorescence microscope with suitable filters. B, ER␤ INS antibody was preincubated overnight with ER␤ 503 protein, which possessed the inserted sequence of rat ER␤ins, and was used for staining. C, ER␤ INS antibody was preincubated with ER␤ 530 protein (wild-type), which has no inserted sequence and was used for staining. Bars, 50 m.
ER␤cx may be more important than wt ER␤, because they can heterodimerize with and act as dominant negative regulators of ER␣ (17) (18) (19) (20) . To be a negative regulator two conditions must be met. These are 1) colocalization with ER␣ in same nuclei, and 2) presence of at least an equimolar ratio of ER␤ and ER␣ proteins. Our double immunostaining shows that the first condition is met in the lactating mammary gland. In the pregnant mammary gland where ER␣ induces progesterone receptor (35) (36) (37) , about 70% of ER␣ is expressed alone and is free from potential inhibition by ER␤ins. However, during the lactation period, colocalization of ER␤ins with ER␣ is increased, and in 70 -80% of ER␣-containing cells ER␣ may be antagonized by ER␤ins.
The second condition, an equimolar ratio of ER␣ and ER␤ins, is more difficult to demonstrate directly. However, as the molar ratio of ER␤ to ER␣ is approximately 3 during lactation, and there is a significant increase in ER␤ins protein in the lactating period, it seems clear that there is sufficient ER␤ins in ER␣-expressing epithelial cells to affect ER␣ function.
It is a well known observation that experimentally the lactating mammary gland is estrogen insensitive, i.e. there is no induction of progesterone receptor by doses of estradiol that are effective in the mammary glands of age-matched virgins (27) (28) (29) . We present the hypothesis that antagonism of ER␣ by ER␤ins may be the source of this insensitivity.
An important question that arises from this hypothesis is whether there are ligands that activate estrogen receptors during the period of lactation. E 2 levels are very low during lactation (38), but there are several possible conditions during which ER␤ins may be needed to prevent activation of ER␣. These include high levels of phyto-or xenoestrogens (39) and activation of ER via phosphorylation by epidermal growth factor-or insulin-like growth factor-stimulated pathways (40, 41) .
A recent paper reported that in the presence of E 2 or raloxifene, ER␤ins can activate the transforming growth factor-␤ promoter as efficiently as ER␣ and wt ER␤ (26) . This indicates that in addition to antagonism of ER␣, ER␤ins may have other functions.
In human tissues ER␤ins is rarely expressed, although ER␤cx is frequently observed in normal human breast tissue (24, 42) . We speculate that human ER␤cx has a role similar to that we have suggested for rat ER␤ins. If in human lactating breast ER␤cx is also induced, antagonism of ER␣ by ER␤cx may occur. This may contribute to the reduced risk of breast cancer in women who breastfeed their babies, which has been reported in epidemiological studies (43) . Further investigation of ER␤ variants in the normal human breast is clearly needed.
